84 related articles for article (PubMed ID: 9719938)
1. Interleukin-1 alpha and interleukin-1 beta production in peripheral whole blood from patients with urological cancer.
Kuo JY; Ohmoto Y; Yoshida O
Hinyokika Kiyo; 1998 Jun; 44(6):397-402. PubMed ID: 9719938
[TBL] [Abstract][Full Text] [Related]
2. An assessment of interleukin-1 alpha and interleukin-1 beta production in patients with bladder cancer.
Kuo JY; Ohmoto Y; Yoshida O
Anticancer Res; 1996; 16(5B):3067-70. PubMed ID: 8920768
[TBL] [Abstract][Full Text] [Related]
3. TNF alpha, IL-1 beta and IL-6 production by peripheral blood monocytes in patients with renal cell carcinoma.
Ikemoto S; Sugimura K; Yoshida N; Wada S; Yamamoto K; Kishimoto T
Anticancer Res; 2000; 20(1A):317-21. PubMed ID: 10769674
[TBL] [Abstract][Full Text] [Related]
4. Tumor-induced dysfunction in interleukin-2 production and interleukin-2 receptor signaling: a mechanism of immune escape.
Rayman P; Uzzo RG; Kolenko V; Bloom T; Cathcart MK; Molto L; Novick AC; Bukowski RM; Hamilton T; Finke JH
Cancer J Sci Am; 2000 Feb; 6 Suppl 1():S81-7. PubMed ID: 10685665
[TBL] [Abstract][Full Text] [Related]
5. Synergetic effect of dialyzer membrane and lipopolysaccharide on peripheral blood mononuclear cell cytokine production in uremic patients.
Gu Y; Ding F; Qin H; Zhao H; Lin S
Chin Med J (Engl); 2000 Apr; 113(4):315-9. PubMed ID: 11775226
[TBL] [Abstract][Full Text] [Related]
6. Renal cell carcinoma induces interleukin 10 and prostaglandin E2 production by monocytes.
Ménétrier-Caux C; Bain C; Favrot MC; Duc A; Blay JY
Br J Cancer; 1999 Jan; 79(1):119-30. PubMed ID: 10408703
[TBL] [Abstract][Full Text] [Related]
7. [Study on urinary levels of interleukin-1 beta, interleukin-6 and tumor necrosis factor-alpha in patients with renal cell carcinoma].
Shi B; Nakazawa H; Ryoji O; Goya N; Ito F; Koga S; Okuda H; Kobayashi H; Toma H
Hinyokika Kiyo; 1998 Mar; 44(3):143-7. PubMed ID: 9589873
[TBL] [Abstract][Full Text] [Related]
8. Cytokine production in primary histoculture by human normal kidney, renal cell carcinoma and benign renal angiomyolipoma tissues.
Chang SG; Shin C; Rho SK; Kim DK; Kim JH
Anticancer Res; 1998; 18(6A):4195-200. PubMed ID: 9891467
[TBL] [Abstract][Full Text] [Related]
9. [Zeta chain level of T and NK cells in patients with renal-cell carcinoma and bladder cancer and its clinical significance].
Han Y; Li CL; Lu L; Zhou CX; Ma WB; Wang DM; Zhang SR
Zhonghua Zhong Liu Za Zhi; 2004 Mar; 26(3):158-60. PubMed ID: 15196436
[TBL] [Abstract][Full Text] [Related]
10. Exogenous interleukin 2 regulates interleukin 6 and nitric oxide but not interferon gamma and tumor necrosis factor alpha production in bronchoalveolar leukocytes from patients with small cell lung cancer.
Cembrzyńska-Nowak M; Bieńkowska M; Szklarz E
Arch Immunol Ther Exp (Warsz); 1998; 46(6):367-74. PubMed ID: 9883316
[TBL] [Abstract][Full Text] [Related]
11. Renal cell carcinoma-associated immune impairment that may interfere with the response to cytokine therapy.
Lauerová L; Dusek L; Simícková M; Rovný F; Spurný V; Rovný A; Slampa P; Zaloudík J; Rejthar A; Wotke J; Kovarík J
Neoplasma; 1999; 46(3):141-9. PubMed ID: 10613588
[TBL] [Abstract][Full Text] [Related]
12. Intracytoplasmatic and extracellular interleukin-1 production by monocytes of lung and colorectal cancer patients.
Chasseing NA; Trejo YG; Bordenave HR; Zanoni L; Rumi LS
Acta Physiol Pharmacol Ther Latinoam; 1997; 47(3):147-56. PubMed ID: 9339244
[TBL] [Abstract][Full Text] [Related]
13. Signal transduction abnormalities in T lymphocytes from patients with advanced renal carcinoma: clinical relevance and effects of cytokine therapy.
Bukowski RM; Rayman P; Uzzo R; Bloom T; Sandstrom K; Peereboom D; Olencki T; Budd GT; McLain D; Elson P; Novick A; Finke JH
Clin Cancer Res; 1998 Oct; 4(10):2337-47. PubMed ID: 9796963
[TBL] [Abstract][Full Text] [Related]
14. Changes in soluble IL-6 receptor and IL-6 production by polymorphonuclear cells and whole blood cells of breast cancer patients.
Jabłońska E; Pietruska Z
Arch Immunol Ther Exp (Warsz); 1998; 46(1):25-9. PubMed ID: 9510942
[TBL] [Abstract][Full Text] [Related]
15. The differential expression of proinflammatory cytokines IL-6, IL-8 and TNF-alpha in renal cell carcinoma.
König B; Steinbach F; Janocha B; Drynda A; Stumm M; Philipp C; Allhoff EP; König W
Anticancer Res; 1999; 19(2C):1519-24. PubMed ID: 10365136
[TBL] [Abstract][Full Text] [Related]
16. Determination of diagnostic and prognostic values of urinary interleukin-8, tumor necrosis factor-alpha, and leukocyte arylsulfatase-A activity in patients with bladder cancer.
Koçak H; Oner-Iyidoğan Y; Koçak T; Oner P
Clin Biochem; 2004 Aug; 37(8):673-8. PubMed ID: 15302609
[TBL] [Abstract][Full Text] [Related]
17. Reduction in cytokine production in colorectal cancer patients: association with stage and reversal by resection.
Heriot AG; Marriott JB; Cookson S; Kumar D; Dalgleish AG
Br J Cancer; 2000 Mar; 82(5):1009-12. PubMed ID: 10737381
[TBL] [Abstract][Full Text] [Related]
18. Interleukin 8 production in whole blood assays: Is interleukin 10 responsible for the downregulation observed in sepsis?
Marie C; Fitting C; Muret J; Payen D; Cavaillon JM
Cytokine; 2000 Jan; 12(1):55-61. PubMed ID: 10623443
[TBL] [Abstract][Full Text] [Related]
19. Complex perioperative immuno-dysfunction in patients with renal cell carcinoma.
Böhm M; Ittenson A; Philipp C; Röhl FW; Ansorge S; Allhoff EP
J Urol; 2001 Sep; 166(3):831-6. PubMed ID: 11490228
[TBL] [Abstract][Full Text] [Related]
20. Role of tumor-associated macrophages in renal cell carcinoma.
Ikemoto S; Yoshida N; Narita K; Wada S; Kishimoto T; Sugimura K; Nakatani T
Oncol Rep; 2003; 10(6):1843-9. PubMed ID: 14534706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
